+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07128524

Evaluating Ketone Supplementation to Reduce Opioid Craving and Withdrawal Symptoms in Adults with Opioid Use Disorder

Led by University of Maryland, Baltimore · Updated on 2026-08-25

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating ketone supplementation KS to see if it reduces opioid cravings and withdrawal symptoms such as low mood and pain in adults with opioid use disorder OUD undergoing in-patient acute withdrawal management. The study compares KS to a placebo in patients entering acute withdrawal treatment. It aims to clarify whether KS can help manage opioid cravings and withdrawal discomfort during this critical period. Participants will be randomly assigned to receive either ketone supplement drinks or placebo drinks three times daily for seven days. The trial uses a quadruple-blind design, meaning neither participants nor researchers know who receives the KS or placebo. The two groups each include about 25 adults, and the intervention lasts for one week. During the study, participants will complete assessments of mood, pain tolerance, and subjective opioid withdrawal symptoms daily, including before treatment begins and through day seven. Researchers will measure craving using the Tonic Craving FORCAST scores at baseline and day seven. The study also evaluates pain sensitivity, desire for drugs, mood ratings, and chronic pain. The total participation duration corresponds to the seven-day treatment period with these regular assessments.

CONDITIONS

Brief Title

Ketones for Opioid Craving

Research Team

P

Peter Manza, PhD

K

Kynah Walston, MA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here